Body mass index and bioelectrical impedance phase angle as potentially modifiable nutritional markers are independent risk factors for outcome in allogeneic hematopoietic cell transplantation

Implications of Obesity for Drug Therapy: Limitations and Challenges

(2011) R Jain et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Physical activity for patients undergoing an allogeneic hematopoietic stem cell transplantation: benefits of a moderate exercise intervention

(2011) Freerk T. Baumann et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Body mass index (BMI) at diagnosis is associated with surgical wound complications in patients with localized osteosarcoma: A report from the Children's Oncology Group

(2011) Pooja Hingorani et al.   PEDIATRIC BLOOD & CANCER

Cutoff percentiles of bioelectrical phase angle predict functionality, quality of life, and mortality in patients with cancer

(2010) Kristina Norman et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Allogeneic transplant outcomes are not affected by body mass index (BMI) in patients with haematological malignancies

(2010) Emmanouil Nikolousis et al.   ANNALS OF HEMATOLOGY

Obesity Does Not Preclude Safe and Effective Myeloablative Hematopoietic Cell Transplantation (HCT) for Acute Myelogenous Leukemia (AML) in Adults

(2010) Willis H. Navarro et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Effects of a partly self-administered exercise program before, during, and after allogeneic stem cell transplantation

(2010) J. Wiskemann et al.   BLOOD

Effect of Obesity on the Pharmacokinetics of Drugs in Humans

(2010) Michael J. Hanley et al.   CLINICAL PHARMACOKINETICS

Perzentilen des Body-Mass-Index auch für 18- bis 80-Jährige? Daten der Nationalen Verzehrsstudie II

(2010) C Hemmelmann et al.   DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT

Standardized phase angle from bioelectrical impedance analysis as prognostic factor for survival in patients with cancer

(2009) Silvana Iturriet Paiva et al.   SUPPORTIVE CARE IN CANCER

Reduced-toxicity conditioning with fludarabine, BCNU, and melphalan in allogeneic hematopoietic cell transplantation: particular activity against advanced hematologic malignancies

(2008) R. Marks et al.   BLOOD

Bioelectrical impedance phase angle as a prognostic indicator in breast cancer

(2008) Digant Gupta et al.   BMC CANCER

Evaluation of nutritional status in patients undergoing hematopoietic SCT

(2008) M Hadjibabaie et al.   BONE MARROW TRANSPLANTATION

Cachexia: A new definition

(2008) William J. Evans et al.   CLINICAL NUTRITION

The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT)

(2008) Margaret F. Bevans et al.   SUPPORTIVE CARE IN CANCER